The primary objective of this study is to assess in real-life settings the effectiveness of conservative treatments on symptoms, signs and quality of life, in patients consulting for CVD
Study Type
OBSERVATIONAL
Enrollment
6,419
Servier Affaires Medicales
Suresnes, France
Global leg symptoms severity
Measured by visual analogue scale (VAS) and questioning with 4 points rate
Time frame: week 4
Global improvement
Measured by Patient Global Impression of Change (PGIC) scale, and time to improvement.
Time frame: Week 4
Disease severity
Measured by VCSS (Venous Clinical Severity score)
Time frame: Week 4
Quality of Life
Measured by CIVIQ-14 questionnaire
Time frame: Week 4
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.